Shivom Revenue and Competitors
Estimated Revenue & Valuation
- Shivom's estimated annual revenue is currently $2.8M per year.
- Shivom's estimated revenue per employee is $155,000
Employee Data
- Shivom has 18 Employees.
- Shivom grew their employee count by 6% last year.
Shivom's People
Name | Title | Email/Phone |
---|
Shivom Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is Shivom?
We are a London-based healthcare data analytics & AI company, building the world's largest genetic & precision medicine data marketplace. Our blockchain and AI-based platform solves several problems the global research community faces (e.g. siloed data, cross-border data sharing, lack of state-of-the-art analytic tools, GDPR-compliance) by providing a next-generation data sharing- & data analytics ecosystem, lifting precision medicine, drug discovery, and translational research into a new era of democratized healthcare. We provide an epidemic preparedness platform; a trusted global data exchange & AI analytics eco-system designed to advance research on, and health responses to, the COVID-19 pandemic and future outbreaks.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Shivom News
Parikant Shivom Shandil.(Middle) with parents Kusum and Harish at their home in Rara Housing Lajonnia Labasa, Photo: Sampras Anand...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.6M | 18 | 0% | $23M |
#2 | $2.3M | 18 | -67% | N/A |
#3 | $2.7M | 18 | -59% | N/A |
#4 | $3.5M | 18 | -50% | N/A |
#5 | $0.9M | 18 | -5% | N/A |